Photo Credit: Blablo101/Shutterstock.com What are the best plants for extracting and making high quality CBD-rich oil? Marijuana, industrial hemp, both? Let’s cut through the legal mumbo jumbo, the obfuscating nomenclature, and the marketing hype and let’s look at what’s really out there for sourcing CBD-rich oil. In the cannabis world there are two types of […]

by

Positive results have been reported from a phase 3 study of the investigational medication cannabidiol (Epidiolex, GW Pharmaceuticals) in patients with Dravet syndrome, a rare and debilitating type of infantile-onset epilepsy for which no treatments are currently available in the U.S. Cannabidiol achieved the trial’s primary endpoint of a significant reduction in convulsive seizures assessed […]

by

Zynerba Pharmaceuticals (NASDAQ:ZYNE), a developer of transdermal synthetic cannabinoid treatments, published data that demonstrates the acidic pH conditions provided by simulated gastric fluid converts cannabidiol (CBD) into psychoactive components tetrahydrocannabinol (THC) and cannabinoids. In a paper titled Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid, which was published online in Cannabis […]

by

London, (GLOBE NEWSWIRE) – GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that it has commenced a Phase 3 clinical trial of Epidiolex® (cannabidiol or CBD) as an adjunctive therapy for the treatment of seizures […]

by

After a fairly traumatic 12 months, Arena Pharmaceuticals ($ARNA) will be looking to ease its own agonies and focus on its research after posting positive Phase I data for its cannabinoid 2 receptor pain drug. The placebo-controlled Phase 1b clinical trial looked at 36 healthy adults to evaluate the safety of multiple-ascending doses of APD371 […]

by

CLEVELAND, March 10, 2016 — Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter and year ended December 31, 2015. “Overall, we have made substantial progress over the past twelve months,” said Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys.  “We have seen that MultiStem® treatment has the potential to […]

by

Getty Alzheimer’s disease (AD) is a chronic, neurodegenerative disorder that is linked to progressive neuronal loss and cognitive decline that typically affects elderly individuals between 65 and 80 years of age. The cause of AD is multi-factorial, including a genetic basis and unknown etiology. AD patients usually suffer cognitive impairment, short and long-term memory loss, […]

COSTA MESA, CA — (Marketwired) — 04/08/16 — Sipp Industries, Inc. (OTC: SIPC), a diversified conglomerate corporation specializing in technology, manufacturing and distribution of commercial and consumer products announces a formal distribution agreement with Ultra Oil for Pets. Sipp Industries, through its wholly owned subsidiary Major Hemp, will begin selling Ultra Oil formulated products to […]

Giving marijuana to kids is usually a criminal offense, rather than grounds for a 100 percent-plus stock price increase. GW Pharma is the exception. On Monday, the company reported its cannabis-derived drug Epidiolex in a late-stage trial substantially reduced the number of seizures in patients with a difficult-to-treat form of pediatric epilepsy called Dravet syndrome.  GW shares jumped 120 percent on the […]

DENVER, CO — (Marketwired) — 04/06/16 — Ubiquitech Software Corp. (www.ubiquitechsoftware.com) (OTC PINK: UBQU), through its operating subsidiary HempLifeToday.com, known for developing the purest and most potent CBD Hemp derived products available and developer of the proprietary CBD brand CannazALL, is announcing new pricing for HempLife Today ™ and its popular CannazALL™ brand of CBD […]